Status:
COMPLETED
Size Progression of Macular Degeneration After Cataract Surgery
Lead Sponsor:
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Collaborating Sponsors:
Medical Scientific Fund of the Mayor of Vienna
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study was to find out if in patients with non-exudative age-related macular degeneration (AMD), randomly assigned to cataract surgery, any AMD size progression or progression to ex...
Eligibility Criteria
Inclusion
- Patients with cataract and non-exudative age-related macular degeneration
Exclusion
- Patients with retinal pathologies other than AMD, exudative AMD, progressive glaucoma, myopia \> 10 diopters, panretinal laser treatment, former cataract or vitreoretinal surgery, were excluded.
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01165801
Start Date
January 1 2002
End Date
July 1 2010
Last Update
July 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Rudolph Foundation Hospital, Dept. of Ophthalmology
Vienna, Vienna, Austria, 1030